Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Schuchter, L' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 14 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wildemore, JK; Schuchter, L; Mick, R; Synnestvedt, M; Elenitsas, R; Bedrosian, I; Czerniecki, BJ; Guerry, D; Lessin, SR; Elder, DE; Bucky, LP
      Locally recurrent malignant melanoma characteristics and outcomes: A single-institution study

      ANNALS OF PLASTIC SURGERY
    2. Chang, JH; Vines, E; Bertsch, H; Fraker, DL; Czerniecki, BJ; Rosato, EF; Lawton, T; Conant, EF; Orel, SG; Schuchter, L; Fox, KR; Zieber, N; Glick, JH; Solin, LJ
      The impact of a multidisciplinary breast cancer center on recommendations for patient management - The University of Pennsylvania experience

      CANCER
    3. Visonneau, S; Cesano, A; Porter, DL; Luger, SL; Schuchter, L; Kamoun, M; Torosian, MH; Duffy, K; Sickles, C; Stadtmauer, EA; Santoli, D
      Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer

      CLINICAL CANCER RESEARCH
    4. Bedrosian, I; Faries, MB; Guerry, D; Elenitsas, R; Schuchter, L; Mick, R; Spitz, FR; Bucky, LP; Alavi, A; Elder, DE; Fraker, DL; Czerniecki, BJ
      Incidence of sentinel node metastasis in patients with thin primary melanoma (<= 1 mm) with vertical growth phase

      ANNALS OF SURGICAL ONCOLOGY
    5. Shaw, LM; Bonner, HS; Schuchter, L; Schiller, J; Lieberman, R
      Pharmacokinetics of amifostine: Effects of dose and method of administration

      SEMINARS IN ONCOLOGY
    6. DiPaola, RS; Schuchter, L
      Neurologic protection by amifostine

      SEMINARS IN ONCOLOGY
    7. Van Belle, PA; Elenitsas, R; Satyamoorthy, K; Wolfe, JT; Guerry, D; Schuchter, L; Van Belle, TJ; Albelda, S; Tahin, P; Herlyn, M; Elder, DE
      Progression-related expression of beta 3 integrin in melanomas and nevi

      HUMAN PATHOLOGY
    8. Alpaugh, RK; von Mehren, M; Palazzo, I; Atkins, MB; Sparano, JA; Schuchter, L; Weiner, LM; Dutcher, JP
      Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon

      MEDICAL ONCOLOGY
    9. Margolis, DJ; Halpern, AC; Rebbeck, T; Schuchter, L; Barnhill, RL; Fine, J; Berwick, M
      Validation of a melanoma prognostic model

      ARCHIVES OF DERMATOLOGY
    10. GRECO FA; FIGLIN R; YORK M; EINHORN L; SCHILSKY R; MARSHALL EM; BUYS SS; FROIMTCHUK MJ; SCHULLER J; SCHUCHTER L; BUYSE M; RITTER L; MAN A; YAP AKL
      PHASE-III RANDOMIZED STUDY TO COMPARE INTERFERON ALFA-2A IN COMBINATION WITH FLUOROURACIL VERSUS FLUOROURACIL ALONE IN PATIENTS WITH ADVANCED COLORECTAL-CANCER

      Journal of clinical oncology
    11. SCHUCHTER L; SCHULTZ DJ; SYNNESTVEDT M; TROCK BJ; GUERRY D; ELDER DE; ELENITSAS R; CLARK WH; HALPERN AC
      A PROGNOSTIC MODEL FOR PREDICTING 10-YEAR SURVIVAL IN PATIENTS WITH PRIMARY MELANOMA

      Annals of internal medicine
    12. SCHUCHTER L; DIPAOLA R; GREENBERG R; BIRD S; MOLLMAN J; RECIO A; LIST A; TAYLOR C; ALBERTS D
      A PHASE-I STUDY OF AMIFOSTINE (AMI) AND ESCALATING DOSES OF TAXOL IN PATIENTS (PTS) WITH ADVANCED CANCER

      European journal of cancer
    13. NAKASHIMA M; JANISZEWSKA M; STEPLEWSKI Z; WATANABE T; SCHUCHTER L; KOPROWSKI H
      PROLIFERATION, PHENOTYPE, AND CYTOTOXICITY OF HUMAN-LYMPHOCYTES ISOLATED FROM LYMPH-NODES INVADED BY MELANOMA-CELLS

      Hybridoma
    14. NAKASHIMA M; WATANABE T; KOPROWSKI H; SCHUCHTER L; STEPLEWSKI Z
      IN-VITRO EXPANSION OF TUMOR-SPECIFIC, HLA-RESTRICTED HUMAN CD8(-LYMPHOCYTES() CYTOLYTIC T)

      Cellular immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 05:22:03